Cerebellomedullary Cistern Delivery for AAV-Based Gene Therapy: A Technical Note for Nonhuman Primates

被引:18
|
作者
Samaranch, Lluis [1 ]
Bringas, John [1 ]
Pivirotto, Philip [1 ]
Sebastian, Waldy San [1 ]
Forsayeth, John [1 ]
Bankiewicz, Krystof [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol Surg, Intervent Neurol Ctr, San Francisco, CA 94103 USA
关键词
CENTRAL-NERVOUS-SYSTEM; TRANSDUCTION;
D O I
10.1089/hgtb.2015.129
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Accessing cerebrospinal fluid (CSF) from the craniocervical junction through the posterior atlanto-occipital membrane via cerebellomedullary injection (also known as cisternal puncture or cisterna magna injection) has become a standard procedure in preclinical studies. Such delivery provides broader coverage to the central and peripheral nervous system unlike local parenchymal delivery alone. As a clinical application, this approach offers a more reliable method for neurological gene replacement delivery in infants, where skull-mounted devices are not indicated. Here we describe a consistent, precise, and safe method for CSF injection with minimal equipment and technical skills.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 50 条
  • [1] Induction of tolerance to the transgene after AAV-based gene transfer to the skeletal muscle of nonhuman primates
    Adjali, Oumeya
    HUMAN GENE THERAPY, 2009, 20 (11) : 1371 - 1371
  • [2] A novel AAV-based gene therapy for glaucoma
    Wu, Ling
    Maturana, Carola
    Yao, Zuliang
    Wang, Wei
    Liang, Bo
    Hong, Laura
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [3] Interplay Between Local Irradiation and AAV-Based Gene Delivery for Cancer Therapy
    Dubrot, Juan
    Marco, Sonia
    Juanarena, Nerea
    Honorato, Beatriz
    Fernandez, Myriam
    Prieto, Jesus
    MOLECULAR THERAPY, 2024, 32 (04) : 386 - 386
  • [4] AAV-based gene replacement: The promise of gene therapy for deafness
    Qi, Jieyu
    Zhang, Liyan
    Chai, Renjie
    MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (02):
  • [5] AAV-based in vivo gene therapy for neurological disorders
    Ling, Qinglan
    Herstine, Jessica A.
    Bradbury, Allison
    Gray, Steven J.
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (10) : 789 - 806
  • [6] AAV-based in vivo gene therapy for neurological disorders
    Qinglan Ling
    Jessica A. Herstine
    Allison Bradbury
    Steven J. Gray
    Nature Reviews Drug Discovery, 2023, 22 : 789 - 806
  • [7] AAV-based gene transfer
    Büning, H
    Nicklin, SA
    Perabo, L
    Hallek, M
    Baker, AH
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (04) : 367 - 375
  • [8] Development of Novel AAV-Based Gene Therapy for Cardiac Disease
    Whittlesey, K.
    Brooks, G.
    Szymanski, P.
    Beliakoff, G.
    Nye, J.
    Croze, R.
    Schmitt, C.
    Bickta, J.
    Barglow, K.
    Kotterman, M.
    Francis, P.
    Schaffer, D.
    Kirn, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [9] In Vivo Potency Assay for AAV-Based Gene Therapy Vectors
    De, Bishnu P.
    Chen, Alvin
    Rosenberg, Jonathan B.
    Chiuchiolo, Maria
    Van de Graaf, Benjamin
    Pagovich, Odelya E.
    Sondhi, Dolan
    Russo, Carlo
    Kaminsky, Stephen M.
    Crystal, Ronald G.
    MOLECULAR THERAPY, 2016, 24 : S186 - S186
  • [10] A Novel AAV-Based Gene Therapy for Spinal Muscular Atrophy
    Wu, Zhenhua
    Zhu, Peixin
    Wang, Qingzeng
    Li, Zhongwan
    Chen, Shuyuan
    Dai, Li
    Li, Junhui
    Wang, Lijun
    Ye, Guojie
    MOLECULAR THERAPY, 2022, 30 (04) : 257 - 257